The immunoprofile of interstitial cajal cells within adenomyosis/endometriosis lesions

Romanian Journal of Morphology and Embryology

Volumn 56, Issue 1, 2015, Pages 133-138

  Drăghici, Isabela Magdalena ^a   Drăghici, Liviu ^a   Cojocaru, Manole ^b   Gorgan, Carmen Loredana ^c   Vrabie, Camelia Doina ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b TITU MAIORESCU UNIVERSITY   (Romania)

^c Sf Ioan Emergency Hospital   (Romania)

Author keywords

Diagnosis; Fertility; Histopathology; Immunohistochemistry; Marker

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; PROTEIN S 100; S100A1 PROTEIN; STEM CELL FACTOR RECEPTOR; VIMENTIN;

ADENOMYOSIS; ADULT; AGED; CYTOLOGY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTERSTITIAL CELL OF CAJAL; METABOLISM; MIDDLE AGED; STROMA CELL;

ADENOMYOSIS; ADULT; AGED; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELLS OF CAJAL; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-KIT; S100 PROTEINS; STROMAL CELLS; VIMENTIN;

EID: 84925293220     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. [1] Gianetto-Berrutti A, Feyles V. Endometriosis related to infertility. Minerva Ginecol, 2003, 55(5):407–416.
2. [2] Cristescu C, Velişcu A, Marinescu B, Pătraşcu A, Traşcă ET, Pop OT. Endometriosis–clinical approach based on histological findings. Rom J Morphol Embryol, 2013, 54(1):91–97.
3. [3] Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril, 1997, 68(4): 585–596.
4. [4] Nap AW, Groothuis PG, Demir AY, Evers JL, Dunselman GA. Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol, 2004, 18(2):233–244.
5. [5] Vercellini P, Aimi G, Panazza S, Vicentini S, Pisacreta A, Crosignani PG. Deep endometriosis conundrum: evidence in favor of a peritoneal origin. Fertil Steril, 2000, 73(5):1043–1046.
6. [6] Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod, 1997, 12(10):2159–2161.
7. [7] Reich H, McGlynn F, Sekel L. Total laparoscopic hysterectomy. Gynecol Endosc, 1993, 2:59–63.
8. [8] Batt RE. Explication and defense of Sampson’s theory of pathogenesis. In: Batt RE. A history of endometriosis. Springer-Verlag, eBook, London, 2011, 179–193.
9. [9] Drăghici I, Drăghici L, Gorgan CL, Popescu MD, Liţescu M, Munteanu R, Ginghină O, Spiridonescu B, Al Rawi AA, Pătru C. Laparoscopic approach of recurrent endometriosis ovarian cysts in adolescents–indications and technical difficulties. In: ***. Book of Abstracts: 1st National Congress of Romanian Society of Paediatric Laparoscopic Surgery, Bucharest, Romania, April 24–26, 2014.
10. [10] Halis G, Mechsner S, Ebert AD. The diagnosis and treatment of deep infiltrating endometriosis. Dtsch Arztebl Int, 2010, 107(25):446–456; quiz 456.
11. [11] Harada T. Dysmenorrhea and endometriosis in young women. Yonago Acta Med, 2013, 56(4):81–84.
12. [12] Machairiotis N, Stylianaki A, Dryllis G, Zarogoulidis P, Kouroutou P, Tsiamis N, Katsikogiannis N, Sarika E, Courcoutsakis N, Tsiouda T, Gschwendtner A, Zarogoulidis K, Sakkas L, Baliaka A, Machairiotis C. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol, 2013, 8:194.
13. [13] Kim AH, Adamson GD. Endometriosis. The Global Library of Women’s Medicine, 2008, http://www.glowm.com/section_view/heading/Endometriosis/item/11.
14. [14] Wheeler JM. Epidemiology and prevalence of endometriosis. Infertil Reprod Med Clin North Am, 1992, 3:545.
15. [15] Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am, 1997, 24(2):235–258.
16. [16] Boling RO, Abbasi R, Ackerman G, Schipul AH Jr, Chaney SA. Disability from endometriosis in the United States Army. J Reprod Med, 1988, 33(1):49–52.
17. [17] Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med, 1989, 34(1):41–46.
18. [18] Houston DE, Noller KL, Melton LJ 3rd, Selwyn BJ, Hardy RJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970–1979. Am J Epidemiol, 1987, 125(6):959–969.
19. [19] Olive DL, Schwartz LB. Endometriosis. N Engl J Med, 1993, 328(24):1759–1769.
20. [20] Clark AH. Endometriosis in a young girl. J Am Med Assoc, 1948, 136(10):690.
21. [21] Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol, 1999, 82(2):129–133.
22. [22] Carvalho LF, Samadder AN, Agarwal A, Fernandes LF, Abrão MS. Oxidative stress biomarkers in patients with endometriosis: systematic review. Arch Gynecol Obstet, 2012, 286(4):1033–1040.
23. [23] Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril, 2002, 77(5): 861–870.
24. [24] Szczepańska M, Koźlik J, Skrzypczak J, Mikołajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril, 2003, 79(6):1288–1293.
25. [25] Ngô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol, 2009, 175(1):225–234.
26. [26] Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology, 2003, 144(7):2870–2881.
27. [27] Andrews WC, Larsen GD. Endometriosis: treatment with hormonal pseudopregnancy and-or operation. Am J Obstet Gynecol, 1974, 118(5):643–651.
28. [28] Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML, Petraglia F. Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil Steril, 2006, 85(3):764–766.
29. [29] Baldassarre M, Giannone FA, Foschini MP, Battaglia C, Busacchi P, Venturoli S, Meriggiola MC. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and-β expression of young women. Int J Impot Res, 2013, 25(5):172–177.
30. [30] Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol, 2012, 7:42.
31. [31] Chen Y, Zhai Y, Jiang X, Zhang Z. Malignant transformation of residual endometriosis following hysterectomy and bilateral salpingo-oophorectomy in a female patient from a family with hereditary non-polyposis colorectal cancer. Oncol Lett, 2013, 5(4):1253–1257.
32. [32] Benoit L, Arnould L, Cheynel N, Diane B, Causeret S, Machado A, Collin F, Fraisse J, Cuisenier J. Malignant extraovarian endometriosis: a review. Eur J Surg Oncol, 2006, 32(1):6–11.
33. [33] Munksgaard PS, Blaakaer J. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol, 2011, 123(1): 157–163.
34. [34] Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest, 2000, 50(Suppl 1):18–25.
35. [35] Corner GW, Hu CY, Hertig AT. Ovarian carcinoma arising in endometriosis. Am J Obstet Gynecol, 1950, 59:760–774.
36. [36] Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg, 1925, 10(1):1–72.
37. [37] Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynaecol, 2006, 20(4):569–582.
38. [38] Dueholm M, Lundorf E, Hansen ES, Sørensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril, 2001, 76(3):588–594.
39. [39] Bohlman ME, Ensor RE, Sanders RC. Sonographic findings in adenomyosis of the uterus. AJR Am J Roentgenol, 1987, 148(4):765–766.
40. [40] Togashi K, Nishimura K, Itoh K, Fujisawa I, Noma S, Kanaoka M, Nakano Y, Itoh H, Ozasa H, Fujii S. Adenomyosis: diagnosis with MR imaging. Radiology, 1988, 166(1 Pt 1):111–114.
41. [41] Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol, 1994, 18(6):535–558.
42. [42] Binder SW, Nieberg RK, Cheng L, al-Jitawi S. Histologic and immunohistochemical analysis of nine endometrial stromal tumors: an unexpected high frequency of keratin protein positivity. Int J Gynecol Pathol, 1991, 10(2):191–197.
43. [43] Imai K, Kanzaki H, Fujiwara H, Kariya M, Okamoto N, Takakura K, Maeda M, Mori T. Expression of aminopeptidase N and neutral endopeptidase on the endometrial stromal cells in endometriosis and adenomyosis. Hum Reprod, 1992, 7(9): 1326–1328.
44. [44] Imai K, Kanzaki H, Mori T. Cell surface peptides in human endometrium. Mol Hum Reprod, 1996, 2(6):425–431.
45. [45] Imai K, Maeda M, Fujiwara H, Okamoto N, Kariya M, Emi N, Takakura K, Kanzaki H, Mori T. Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase. Biol Reprod, 1992, 46(3):328–334.
46. [46] Seidl K, Erck C, Buchberger A. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol, 1998, 176(1):10–21.
47. [47] Shipp MA, Stefano GB, D’Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B, Reinherz EL. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature, 1990, 347(6291):394–396.
48. [48] Sumathi VP, McCluggage WG. CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J Clin Pathol, 2002, 55(5):391–392.